Eric Mühlberg
Has participated in:
-
Oral Delivery of the Vancomycin Derivative FU002 by a Surface‐Modified Liposomal Nanocarrier
-
Vancomycin-lipopeptide conjugates with high antimicrobial activity on vancomycin-resistant enterococci
-
Impact of linker modification and PEGylation of vancomycin conjugates on structure-activity relationships and pharmacokinetics